Medical XpressGradual release of immunotherapy at site of tumor surgery prevents tumors from returningMedical XpressMoreover, administering immunotherapy prior to surgery could potentially produce immune-related side effects that could require delaying… Continue reading
Gizmodo |
Doctors Perform Breakthrough FDA-Approved Gene Therapy on 13-Year-Old Boy
Gizmodo On Tuesday, a 13-year-old boy from New Jersey was at the center of medical history as he became the first person in the US to receive an FDA-approved gene therapy for an inherited disease. The event marks the beginning of a new era of medicine, one in … Teen undergoes revolutionary gene therapy procedureBoston Herald Blind Boy Might Be Able to See Again After New Breakthrough Gene Therapy SurgeryNewsweek Children’s Hospital Los Angeles treats first patient on the west coast using gene therapyEurekAlert (press release) The Wall Street Transcript all 6 news articles » |
|
Immunotherapy Trials for Food Allergy Hold Strong Appeal for Parents
Newswise (press release) Newswise — Two-thirds of surveyed caregivers felt that their child’s food allergy affected their own daily lives very much or extremely, according to a report in the Annals of Allergy, Asthma and Immunology. Two-thirds of caregivers also expressed … New info available for allergy patientsValdosta Daily Times |
Boston Herald |
Teen undergoes revolutionary gene therapy procedure
Boston Herald The surgery involves injecting a copy of the missing gene underneath the retina. Comander said the effects won’t be obvious until about a month after the surgery. The treatment is called Luxturna and is made by Spark Therapeutics in Philadelphia. It … Doctors Perform Breakthrough FDA-Approved Gene Therapy on 13-Year-Old BoyGizmodo Blind Boy Might Be Able to See Again After New Breakthrough Gene Therapy SurgeryNewsweek Children’s Hospital Los Angeles Treats First Patient on the West Coast Using Gene TherapyBusiness Wire (press release) The Wall Street Transcript all 6 news articles » |
IAM (blog) |
Industry report – IP trend evaluation – CAR T-cell therapy
IAM (blog) Chimeric antigen receptor (CAR) T-cell therapy is transforming the way that cancer is treated. It is an innovative immunotherapy treatment which uses patients’ immune cells to target tumours. Chemotherapy and radiation therapy have long been the major … |